T 1061/16 (Solid pharmaceutical dosage form comprising a ritonavir and lopinavir solid dispersion/AbbVie Inc.) of 12.03.2019
- European Case Law Identifier
- ECLI:EP:BA:2019:T106116.20190312
- Date of decision
- 12 March 2019
- Case number
- T 1061/16
- Petition for review of
- -
- Application number
- 10181250.1
- IPC class
- A61K 9/20A61K 9/14A61K 31/425
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Solid pharmaceutical dosage form comprising a ritonavir and lopinavir solid dispersion
- Applicant name
- AbbVie Inc.
- Opponent name
- Teva Pharmaceutical Industries LTD.
- Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(b)European Patent Convention Art 123(2)European Patent Convention Art 56European Patent Convention Art 76(1)
- Keywords
- Amendments (Yes)
Sufficiency of disclosure (Yes)
Inventive step (Yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- T 1728/16
Order
For these reasons it is decided that:
The appeal is dismissed.